Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5373-5381

  Hargreaves, Chantal E ^a   Grasso, Marco ^b   Hampe, Christiane S ^c   Stenkova, Anna ^d   Atkinson, Steve ^b   Joshua, George W P ^e   Wren, Brendan W ^e   Buckle, Ashley M ^f   Dunn Walters, Deborah ^a   Banga, J Paul ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ENVELOPE PROTEIN; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; PORIN; THYROID STIMULATING IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; BACTERIAL GENE; CONTROLLED STUDY; CROSS REACTION; GENE REARRANGEMENT; GENETIC VARIABILITY; GERM LINE; GRAVES DISEASE; KSAB1 GENE; KSAB2 GENE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SOMATIC HYPERMUTATION; YERSINIA ENTEROCOLITICA;

ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; GENE EXPRESSION; GERM-LINE MUTATION; GRAVES DISEASE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOGLOBULINS, THYROID-STIMULATING; PROTEIN BINDING; PROTEIN SUBUNITS; RECEPTORS, THYROTROPIN; RECOMBINANT PROTEINS; YERSINIA ENTEROCOLITICA;

EID: 84878044427     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203412     Document Type: Article

References (52)

1. Rees Smith, B., S. M. McLachlan, and J. Furmaniak. 1988. Autoantibodies to the thyrotropin receptor. Endocr. Rev. 9: 106-121.
2. Zakarija, M. 1983. Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. J. Clin. Lab. Immunol. 10: 77-85. (Pubitemid 13139980)
3. Williams, R. C., Jr., N. J. Marshall, K. Kilpatrick, J. Montano, P. M. Brickell, M. Goodall, P. A. Ealey, B. Shine, A. P. Weetman, and R. K. Craig. 1988. κ/λ immunoglobulin distribution in Graves' thyroid-stimulating antibodies: simultaneous analysis of Cλ gene polymorphisms. J. Clin. Invest. 82: 1306-1312.
4. Weetman, A. P., M. E. Yateman, P. A. Ealey, C. M. Black, C. B. Reimer, R. C. Williams, Jr., B. Shine, and N. J. Marshall. 1990. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J. Clin. Invest. 86: 723-727. (Pubitemid 20327359)
5. McLachlan, S. M., H. A. Aliesky, C. R. Chen, R. W. Williams, and B. Rapoport. 2011. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease. PLoS ONE 6: e21378.
6. Rapoport, B., R. W. Williams, C. R. Chen, and S. M. McLachlan. 2010. Immunoglobulin heavy chain variable region genes contribute to the induction of thyroid-stimulating antibodies in recombinant inbred mice. Genes Immun. 11: 254-263.
7. Sanders, J., J. Jeffreys, H. Depraetere, T. Richards, M. Evans, A. Kiddie, K. Brereton, M. Groenen, Y. Oda, J. Furmaniak, and B. Rees Smith. 2002. Thyroid-stimulating monoclonal antibodies. Thyroid 12: 1043-1050. (Pubitemid 36114811)
8. Costagliola, S., M. Bonomi, N. G. Morgenthaler, J. Van Durme, V. Panneels, S. Refetoff, and G. Vassart. 2004. Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol. Endocrinol. 18: 3020-3034. (Pubitemid 39577923)
9. Gilbert, J. A., A. G. Gianoukakis, S. Salehi, J. Moorhead, P. V. Rao, M. Z. Khan, A. M. McGregor, T. J. Smith, and J. P. Banga. 2006. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways. J. Immunol. 176: 5084-5092.
10. Flynn, J. C., J. A. Gilbert, C. Meroueh, D. P. Snower, C. S. David, Y. C. Kong, and J. P. Banga. 2007. Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice. Immunology 122: 261-267. (Pubitemid 47389954)
11. Sanders, J., M. Evans, L. D. Premawardhana, H. Depraetere, J. Jeffreys, T. Richards, J. Furmaniak, and B. Rees Smith. 2003. Human monoclonal thyroid stimulating autoantibody. Lancet 362: 126-128. (Pubitemid 36831025)
12. Evans, M., J. Sanders, T. Tagami, P. Sanders, S. Young, E. Roberts, J. Wilmot, X. Hu, K. Kabelis, J. Clark, et al. 2010. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin. Endocrinol. 73: 404-412.
13. Furmaniak, J., J. Sanders, S. Young, K. Kabelis, P. Sanders, M. Evans, J. Clark, J. Wilmot, and B. Rees Smith. 2012. In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70). Autoimmunity Highlights 3: 19-25.
14. Sanders, J., D. Y. Chirgadze, P. Sanders, S. Baker, A. Sullivan, A. Bhardwaja, J. Bolton, M. Reeve, N. Nakatake, M. Evans, et al. 2007. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17: 395-410. (Pubitemid 46878842)
15. Sanders, P., S. Young, J. Sanders, K. Kabelis, S. Baker, A. Sullivan, M. Evans, J. Clark, J. Wilmot, X. Hu, et al. 2011. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J. Mol. Endocrinol. 46: 81-99.
16. Núñez Miguel, R., J. Sanders, P. Sanders, S. Young, J. Clark, K. Kabelis, J. Wilmot, M. Evans, E. Roberts, X. Hu, et al. 2012. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor. J. Mol. Endocrinol. 49: 137-151.
17. Tomer, Y., and A. Huber. 2009. The etiology of autoimmune thyroid disease: a story of genes and environment. J. Autoimmun. 32: 231-239.
18. Brix, T. H., and L. Hegedüs. 2012. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin. Endocrinol. (Oxf.) 76: 457-464.
19. Bech, K., J. H. Larsen, J. M. Hansen, and J. Nerup. 1974. Letter: Yersinia enterocolitica infection and thyroid disorders. Lancet 2: 951-952.
20. Lidman, K., U. Eriksson, A. Fagraeus, and R. Norberg. 1974. Letter: antibodies against thyroid cells in Yersinia enterocolitica infection. Lancet 2: 1449.
21. Shenkman, L., and E. J. Bottone. 1976. Antibodies to Yersinia enterocolitica in thyroid disease. Ann. Intern. Med. 85: 735-739.
22. Weiss, M., S. H. Ingbar, S. Winblad, and D. L. Kasper. 1983. Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science 219: 1331-1333. (Pubitemid 13109166)
23. Heyma, P., L. C. Harrison, and R. Robins-Browne. 1986. Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease. Clin. Exp. Immunol. 64: 249-254. (Pubitemid 16102147)
24. Wenzel, B. E., J. Heesemann, K. W. Wenzel, and P. C. Scriba. 1988. Antibodies to plasmid-encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1: 56. (Pubitemid 18017232)
25. Luo, G., J. L. Fan, G. S. Seetharamaiah, R. K. Desai, J. S. Dallas, N. Wagle, R. Doan, D. W. Niesel, G. R. Klimpel, and B. S. Prabhakar. 1993. Immunization of mice with Yersinia enterocolitica leads to the induction of antithyrotropin receptor antibodies. J. Immunol. 151: 922-928. (Pubitemid 23215758)
26. Guarneri, F., D. Carlotta, G. Saraceno, F. Trimarchi, and S. Benvenga. 2011. Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid 21: 1283-1284.
27. Nicholson, L. B., H. Vlase, P. Graves, M. Nilsson, J. Molne, G. C. Huang, N. G. Morgenthaler, T. F. Davies, A. M. McGregor, and J. P. Banga. 1996. Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells. J. Mol. Endocrinol. 16: 159-170. (Pubitemid 26157014)
28. Andresen, H., K. Zarse, C. Grötzinger, J. M. Hollidt, E. Ehrentreich-Förster, F. F. Bier, and O. J. Kreuzer. 2006. Development of peptide microarrays for epitope mapping of antibodies against the human TSH receptor. J. Immunol. Methods 315: 11-18. (Pubitemid 44414818)
29. Wang, Z., Q. Zhang, J. Lu, F. Jiang, H. Zhang, L. Gao, and J. Zhao. 2010. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves' disease and determination of its epitope using mass spectrometry and bioinformatics tools. J. Clin. Endocrinol. Metab. 95: 4012-4020.
30. Padoa, C. J., S. L. Larsen, C. S. Hampe, J. A. Gilbert, E. Dagdan, L. Hegedus, D. Dunn-Walters, and J. P. Banga. 2010. Clonal relationships between thyroid-stimulating hormone receptor-stimulating antibodies illustrate the effect of hypermutation on antibody function. Immunology 129: 300-308.
31. Ray, S. K., C. Putterman, and B. Diamond. 1996. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc. Natl. Acad. Sci. USA 93: 2019-2024. (Pubitemid 26079874)
32. Molina, V., and Y. Shoenfeld. 2005. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38: 235-245. (Pubitemid 40959897)
33. Kolm-Litty, V., S. Berlo, E. Bonifacio, M. Bearzatto, A. M. Engel, M. Christie, A.-G. Ziegler, T. Wild, and J. Endl. 2000. Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen. J. Immunol. 165: 4676-4684.
34. Ajjan, R. A., and A. P. Weetman. 2008. Techniques to quantify TSH receptor antibodies. Nat. Clin. Pract. Endocrinol. Metab. 4: 461-468.
35. Metcalfe, R., N. Jordan, P. Watson, S. Gullu, M. Wiltshire, M. Crisp, C. Evans, A. Weetman, and M. Ludgate. 2002. Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. J. Clin. Endocrinol. Metab. 87: 1754-1761. (Pubitemid 34615265)
36. Luo, G., G. S. Seetharamaiah, D. W. Niesel, H. Zhang, J. W. Peterson, B. S. Prabhakar, and G. R. Klimpel. 1994. Purification and characterization of Yersinia enterocolitica envelope proteins which induce antibodies that react with human thyrotropin receptor. J. Immunol. 152: 2555-2561. (Pubitemid 24097949)
37. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin. 2004. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25: 1605-1612.
38. Eswar, N., B. Webb, M. A. Marti-Renom, M. S. Madhusudhan, D. Eramian, M. Y. Shen, U. Pieper, and A. Sali. 2007. Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. Chapter 2: Unit 29.
39. McNicholas, S., E. Potterton, K. S. Wilson, and M. E. Noble. 2011. Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr. D Biol. Crystallogr. 67: 386-394.
40. Ozawa, Y., and S. Mizushima. 1983. Regulation of outer membrane porin protein synthesis in Escherichia coli K-12: ompF regulates the expression of ompC. J. Bacteriol. 154: 669-675. (Pubitemid 13081003)
41. Yamashita, E., M. V. Zhalnina, S. D. Zakharov, O. Sharma, and W. A. Cramer. 2008. Crystal structures of the OmpF porin: function in a colicin translocon. EMBO J. 27: 2171-2180.
42. Baslé, A., G. Rummel, P. Storici, J. P. Rosenbusch, and T. Schirmer. 2006. Crystal structure of osmoporin OmpC from E. coli at 2.0 A. J. Mol. Biol. 362: 933-942. (Pubitemid 44353521)
43. Smith, S. G., V. Mahon, M. A. Lambert, and R. P. Fagan. 2007. A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol. Lett. 273: 1-11. (Pubitemid 47024891)
44. + memory B cells. Immunity 26: 205-213.
45. Guo, W., D. Smith, K. Aviszus, T. Detanico, R. A. Heiser, and L. J. Wysocki. 2010. Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J. Exp. Med. 207: 2225-2237.
46. Wellmann, U., M. Letz, M. Herrmann, S. Angermüller, J. R. Kalden, and T. H. Winkler. 2005. The evolution of human anti-double-stranded DNA autoantibodies. Proc. Natl. Acad. Sci. USA 102: 9258-9263. (Pubitemid 40923551)
47. Schroeder, K., M. Herrmann, and T. H. Winkler. 2013. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity 46: 121-127.
48. Detanico, T., J. B. St Clair, K. Aviszus, G. Kirchenbaum, W. Guo, and L. J. Wysocki. 2013. Somatic mutagenesis in autoimmunity. Autoimmunity 46: 102-114.
49. Di Zenzo, G., G. Di Lullo, D. Corti, V. Calabresi, A. Sinistro, F. Vanzetta, B. Didona, G. Cianchini, M. Hertl, R. Eming, et al. 2012. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. J. Clin. Invest. 122: 3781-3790.
50. Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67: 593-656. (Pubitemid 37549772)
51. Sanders, J., J. Bolton, P. Sanders, J. Jeffreys, N. Nakatake, T. Richards, M. Evans, A. Kiddie, S. Summerhayes, E. Roberts, et al. 2006. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid 16: 1195-1206. (Pubitemid 46080164)
52. Mizutori, Y., C. R. Chen, F. Latrofa, S. M. McLachlan, and B. Rapoport. 2009. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease. J. Clin. Endocrinol. Metab. 94: 927-935.